Recent news on MS: natalizumab is beneficial, stem cell transplantation is not, and the differentiation of neuromyelitis optica and MS is complex

By Strupp Michael  

Journal of Neurology, Vol. 254, Iss. 6, 2007-06 ,pp. : 820-822

Springer Publishing Company

Access to resources Recommend Favorite

Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy

By Lonergan Roisin M   Carr Michael J   De Gascun Cillian F   Costelloe Lisa F   Waters Allison   Coughlan Suzie   Duggan Marguerite   Doyle Katie   Jordan Sinead   Hutchinson Michael W   Hall William W   Tubridy Niall J  

Journal of NeuroVirology, Vol. 15, Iss. 5-6, 2009-12 ,pp. : 351-359

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis

By Carcelén-Gadea María   Ferrer-Garcia Juan   Cervelló Donderis Angeles  

Neurological Sciences, Vol. 34, Iss. 12, 2013-12 ,pp. : 2259-2261

Springer Publishing Company

Access to resources Recommend Favorite

Anticipatory Symptoms and Anticipatory Immune Responses in Pediatric Cancer Patients Receiving Chemotherapy: Features of a Classically Conditioned Response?

By Stockhorst U.   Spennes-Saleh S.   Körholz D.   Göbel U.   Schneider M.E.   Steingrüber H-J.   Klosterhalfen S.  

Brain, Behavior, and Immunity, Vol. 14, Iss. 3, 2000-09 ,pp. : 198-218

Academic Press

Access to resources Recommend Favorite

Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up

By Melis Marta   Cocco Eleonora   Frau Jessica   Lorefice Lorena   Fenu Giuseppe   Coghe Giancarlo   Mura Marco   Marrosu Maria  

Neurological Sciences, Vol. 35, Iss. 3, 2014-03 ,pp. : 401-408

Springer Publishing Company

Access to resources Recommend Favorite